Skip to main content

Table 2 The chi-square test of the relationship between risk score and clinical features in ICGC cohort

From: Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma

Clinical feature

Risk Score

c2

P

High risk n(%)

Low risk n(%)

Age

  

0.899

0.343

 >65

61 (43.57%)

79 (56.43%)

  

  ≤ 65

44 (50%)

44 (50%)

  

Gender

  

0.001

0.978

 female

28 (45.91%)

33 (54.10%)

  

 male

77 (46.11%)

90 (53.89%)

  

Prior Malignancy

  

0.292

0.589

 no

93 (46.73%)

106 (53.27%)

  

 yes

12 (41.38%)

17 (58.62%)

  

Stage

  

9.806

0.002

 I-II

53 (37.32%)

87 (62.68%)

  

 III-IV

52 (59.09%)

36 (40.91%)